Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Famotidine is a histamine H2 receptor antagonist used to treat duodenal ulcers, benign gastric ulcers, GERD, and Zollinger-Ellison syndrome. Famotidine is a competitive histamine-2 (H2) receptor antagonist that works to inhibit gastric acid secretion.
- Mechanism
- Curator reviewed · 2 references
Histamine acts as a local hormone that stimulates the acid output by parietal cells via a paracrine mechanism. Neuroendocrine cells called enterochromaffin-like (ECL) cells lie close to the parietal cells and regulate the basal secretion of histamine. Histamine release is also promoted from stimulation by acetylcholine and gastrin, a peptide hormone. Gastrin (G) cells release gastrin, which works on CCK2 receptors on ECL cells. This action promotes the release of histamine from ECL cells. Upon release, histamine acts on H2 receptors expressed on the basolateral membrane of parietal cells, leading to increased intracellular cAMP levels and activated proton pumps on parietal cells. Proton pump releases more protons into the stomach, thereby increasing the secretion of acid. In conditions that are associated with acid hypersecretion such as ulcers, there is a loss of regulation of acid secretion. Famotidine works on H2 receptors and blocks the actions of histamine.
- Primary indication
- Famotidine is indicated in pediatric and adult patients (with the bodyweight of 40 kg and above) for the management of active duodenal ulcer (DU), active gastric ulcer, symptomatic non-erosive gastroesophageal reflux disease (GERD), and erosive...Curator reviewed · 21 structured indications
- Formula / weight
- C8H15N7O2S3 · 337.445 g/mol (avg)
- First approval
- Canada, 1997 · United States, 1986
- Code names
- L 643341 · MK-208 · YM-11170
- Brand names
- Duo Fusion
- Fluxid
- Good Sense Acid Reducer
- Pepcid
- Pepcid Complete
- Zantac Reformulated Aug 2022
Resolves to
XUFQPHANEAPEMJ-UHFFFAOYSA-NSMILESNC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1What you can answer from here — as of September 23, 2026
Which drugs share a target with Famotidine, and which of those have an active Phase 3 trial?